Chemoinformaics analysis of Delphinidin 3,5-bis(6-O-malonylglucoside)
| Molecular Weight | 799.62 | nRot | 13 |
| Heavy Atom Molecular Weight | 764.34 | nRig | 16 |
| Exact Molecular Weight | 799.156 | nRing | 5 |
| Solubility: LogS | -5.254 | nHRing | 3 |
| Solubility: LogP | 5.986 | No. of Aliphatic Rings | 2 |
| Acid Count | 2 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 91 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 2 |
| nHetero | 23 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 23 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 96.8938 |
| nHD | 12 | BPOL | 50.7362 |
| QED | 0.063 |
| Synth | 5.015 |
| Natural Product Likeliness | 1.555 |
| NR-PPAR-gamma | 0.867 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.045 |
| Pgp-sub | 0.194 |
| HIA | 0.09 |
| CACO-2 | -5.069 |
| MDCK | 0.00000991 |
| BBB | 0.005 |
| PPB | 0.969708 |
| VDSS | 1.025 |
| FU | 0.0281416 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.409 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.869 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.075 |
| CYP3a4-inh | 0.158 |
| CYP3a4-sub | 0.058 |
| CL | 11.004 |
| T12 | 0.05 |
| hERG | 0.16 |
| Ames | 0.047 |
| ROA | 0.108 |
| SkinSen | 0.967 |
| Carcinogencity | 0.041 |
| EI | 0.011 |
| Respiratory | 0.474 |
| NR-Aromatase | 0.848 |
| Antiviral | Yes |
| Prediction | 0.701293 |